Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PROSC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PSME4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3BP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK17A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNGTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STYXL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SF3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB22A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENTPD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB11FIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBFA2T2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on